{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:45:24Z","timestamp":1789051524214,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1482,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jcin.2009.05.018","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T04:21:39Z","timestamp":1250655699000},"page":"748-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies"],"prefix":"10.1016","volume":"2","author":[{"given":"Roxana","family":"Mehran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Nikolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Feit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Manoukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2009.05.018_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.0000016359.94919.16","volume":"105","author":"Januzzi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9149(03)00970-6","article-title":"Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials","volume":"92","author":"Bhatt","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ahj.2004.12.002","article-title":"The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb\/IIIa inhibitors: the Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial","volume":"149","author":"Berger","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.05.018_bib5","first-page":"1343","article-title":"The renal patient with coronary artery disease: current concepts and dilemmas","volume":"44","author":"Gupta","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","article-title":"Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents","volume":"95","author":"Lemos","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2005.03.018","article-title":"Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention","volume":"151","author":"Blackman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.05.018_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.105.591990","article-title":"Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up","volume":"113","author":"Hillis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","article-title":"Chronic kidney disease in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"119","author":"Han","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jcin.2009.05.018_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjcard.2004.11.003","article-title":"Bivalirudin versus heparin and glycoprotein IIb\/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)","volume":"95","author":"Chew","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00129784-200505050-00002","article-title":"Anticoagulant use in patients with chronic renal impairment","volume":"5","author":"Grand'Maison","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jcin.2009.05.018_bib12","doi-asserted-by":"crossref","first-page":"105S","DOI":"10.1592\/phco.22.10.105S.33616","article-title":"Clinical pharmacology of bivalirudin","volume":"22","author":"Reed","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcin.2009.05.018_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02827247","article-title":"Increased thrombin generation in patients with chronic renal failure","volume":"27","author":"Sagripanti","year":"1997","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.jcin.2009.05.018_bib14","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.05.018_bib15","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.05.018_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2004.04.036","article-title":"Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale","volume":"148","author":"Stone","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.05.018_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.05.018_bib18","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.105.580084","article-title":"Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database","volume":"113","author":"Cooper","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1081\/JDI-100104737","article-title":"C reactive protein in patients with chronic renal diseases","volume":"23","author":"Panichi","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.jcin.2009.05.018_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcin.2009.05.018_bib23","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1046\/j.1523-1755.2001.00040.x","article-title":"Coronary artery disease in uremia: etiology, diagnosis, and therapy","volume":"60","author":"Goldsmith","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcin.2009.05.018_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0002-9149(02)02308-1","article-title":"Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency","volume":"89","author":"Jeremias","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9149(02)02991-0","article-title":"Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT trial)","volume":"91","author":"Reddan","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.05.018_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib28","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non\u2013ST-elevation acute coronary syndromes: a risk model from the ACUITY trial","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2009.05.018_bib29","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.05.018_bib30","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2005.09.080","article-title":"Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial","volume":"47","author":"Kirtane","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.05.018_bib31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archinte.167.14.1539","article-title":"Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"167","author":"LaPointe","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2009.05.018_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ahj.2005.04.020","article-title":"Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?","volume":"151","author":"Hernandez","year":"2006","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:55:44Z","timestamp":1761846944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879809003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1936879809003598"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2009.05.018","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2009.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}